Histidine-Tryptophan-Ketoglutarate and Delayed Graft Function After Prolonged Cold Ischemia

被引:4
|
作者
Corps, C. L. [1 ]
Shires, M. [1 ]
Crellin, D. [1 ]
Smolenski, R. [1 ]
Pratt, J. [1 ]
Potts, D. [1 ]
Lodge, J. P. A. [1 ]
机构
[1] St Jamess Univ Teaching Hosp, Dept Hepatobiliary & Transplant Surg, Leeds LS9 7TF, W Yorkshire, England
关键词
UNIVERSITY-OF-WISCONSIN; LIVER-TRANSPLANTATION; HTK SOLUTION; PRESERVATION; UW;
D O I
10.1016/j.transproceed.2009.04.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Several articles have compared histidine-tryptophan-ketoglutarate solution (HTK) with other preservation solutions in both liver and kidney transplantation, and the results suggest that HTK is as good or better than the criterion standard University of Wisconsin solution (UW) for short periods of cold ischemia, such as in live donation, but that it is not so efficient for longer periods of cold ischemia, causing a higher incidence of delayed graft function. Objective. To evaluate energy levels, metabolites, and histologic findings to determine why HTK is inefficient for longer periods of cold ischemia. Methods. Rat livers were perfused with either HTK or UW, and at various times, tissue samples were obtained for analysis of adenine triphosphate and metabolites using high-performance liquid chromatography or for histologic analysis. Results. The high energy charge observed with HTK-perfused livers plateaued after 5 minutes, and by 60 minutes began to decrease, following the same trend as other samples. The plateau is due to excess available glucose; however, after 1 hour, it is beginning to be consumed. Low levels of uridine, required for glycogen synthesis, are found in HTK-perfused livers, which suggests that at reperfusion, there is none available, whereas the higher concentrations found in UW-perfused livers may be advantageous after reperfusion. This will be especially detrimental to use of HTK because glycogen is used up rapidly because of the presence of alpha-ketoglutarate in the solution, enabling continuation of the tricarboxylic acid cycle. Conclusions. Overall, HTK seems to do well for the first 2 hours, after which any advantage observed initially starts to disappear. A liver perfused in HTK and transplanted after more than I hour reacts like an organ from an individual who has been starved, because of the low energy charge and absence of a glycogen store or ability to synthesis glycogen because of lack of uridine. Livers perfused with UW demonstrate higher levels of uridine and do not lose their glycogen content to the same extent as HTK-perfused livers. These findings explain in part why HTK sometimes causes delayed graft function after longer periods of cold ischemia.
引用
收藏
页码:3567 / 3570
页数:4
相关论文
共 50 条
  • [11] Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature
    Fridell, Jonathan A.
    Mangus, Richard S.
    Tector, A. J.
    CLINICAL TRANSPLANTATION, 2009, 23 (03) : 305 - 312
  • [12] Histidine-Tryptophan-Ketoglutarate Solution for Donor Heart Preservation Is Safe for Transplantation
    Mokbel, Majd
    Zamani, Haniyeh
    Lei, Ienglam
    Chen, Y. Eugene
    Romano, Matthew A.
    Aaronson, Keith D.
    Haft, Jonathan W.
    Pagani, Francis D.
    Tang, Paul C.
    ANNALS OF THORACIC SURGERY, 2020, 109 (03) : 763 - 770
  • [13] del Nido cardioplegia better preserves cardiac diastolic function but histidine-tryptophan-ketoglutarate is better for endothelial function
    Xue, Hong-Mei
    Hou, Hai-Tao
    Sun, Wen-Tao
    Wang, Shi-Fu
    Guo, Shan
    Yang, Qin
    He, Guo-Wei
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 61 (06) : 1368 - 1378
  • [14] Comparative study between fructose 1-6 bisphosphate and histidine-tryptophan-ketoglutarate in liver preservation in rats submitted to total cold ischemia
    Smecellato, Fernanda Bombonato
    Benfatti Marsilli, Lucas Ricardo
    Nakamura, Julia Eico
    Jordani, Maria Cecilia
    Barbosa Evora, Paulo Roberto
    Castro-e-Silva, Orlando
    ACTA CIRURGICA BRASILEIRA, 2020, 35 (06) : 1 - 8
  • [15] Comparison of Histidine-Tryptophan-Ketoglutarate and University of Wisconsin preservation solutions inpediatric liver transplantation
    Mangus, Richard S.
    Schroering, Joel R.
    Hathaway, Taylor J.
    Kubal, Chandrashekhar A.
    Fridell, Jonathan A.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (06)
  • [16] Increased Primary Non-Function in Transplanted Deceased-Donor Kidneys Flushed with Histidine-Tryptophan-Ketoglutarate Solution
    Stevens, R. B.
    Skorupa, J. Y.
    Rigley, T. H.
    Yannam, G. R.
    Nielsen, K. J.
    Schriner, M. E.
    Skorupa, A. J.
    Murante, A.
    Holdaway, E.
    Wrenshall, L. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1055 - 1062
  • [17] Histidine-Tryptophan-Ketoglutarate or Celsior: Which Is More Suitable for Cold Preservation for Cardiac Grafts From Older Donors?
    Lee, Sungsoo
    Huang, Chien-Sheng
    Kawamura, Tomohiro
    Shigemura, Norihisa
    Billiar, Timothy R.
    Nakao, Atsunori
    Toyoda, Yoshiya
    ANNALS OF THORACIC SURGERY, 2011, 91 (03) : 755 - 763
  • [18] Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: A cautionary tale
    Alonso, D.
    Dunn, T. B.
    Rigley, T.
    Skorupa, J. Y.
    Schriner, M. E.
    Wrenshall, L. E.
    Stevens, R. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (09) : 1942 - 1945
  • [19] Deceased Donor Flush Volume Similar for Histidine-Tryptophan-Ketoglutarate and University of Wisconsin at a Single US Organ Procurement Organization: Adult and Pediatric Data
    Mangus, Anna E.
    Kubal, Chandrashekhar A.
    Ekser, Burcin
    Mihaylov, Plamen
    Lutz, Andrew J.
    Fridell, Jonathan A.
    Mangus, Richard S.
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (09) : 2016 - 2022
  • [20] Single-Shot Cold Histidine-Tryptophan-Ketoglutarate Cardioplegia for Long Aortic Cross-Clamping Durations in Neonates
    Dolcino, Andrea
    Gaudin, Regis
    Pontailler, Margaux
    Raisky, Olivier
    Vouhe, Pascal
    Bojan, Mirela
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (04) : 959 - 965